Poland – Pharmaceutical products – Dostawa produktów leczniczych.
awardedBiałostockie Centrum Onkologii im. M. Skłodowskiej-Curie w Białymstoku · 9661330466
Value
PLN 93m
Published
27 Oct 2026
Deadline
—
Type
award
33600000 · Medical equipment, pharmaceuticals & personal carePL841
Description
Środek kontrastowy niskiego ryzyka. Przedmiot zamówienia został szczegółowo opisany w Załączniku nr 2 do SWZ.
Key facts
- Procedure
- open
- Regime
- publicSector
- Contract references
- 134568212225273032333424363738414243444649
- Category
- supplies
Awarded suppliers
- Urtica Sp. z o.o. · 932081801 · PL514, PL
- Asclepios S.A. · 272636951 · PL514, PL
- Tramco Sp. z o.o. · 141098662 · PL911, PL
- Amgen Sp. z o.o. · 5272420782 · PL911, PL
- Baxter Polska Sp. z o.o. · 730920652 · PL911, PL
- Janssen-Cilag Polska Sp. z o.o. · 015296339 · PL911, PL
- Astellas Pharma Sp. z o.o. · 012773490 · PL911, PL
- Astrazeneca Kft. · HU110, HU
- Sanofi Sp. z o.o. · 690135895 · PL911, PL
Bid competition
Who else bid, as published on the notice. A bid is an offer, not money paid: nothing in this section is an award, and a firm named here was not necessarily paid anything.
Firms that bid
Farmacol-Logistyka Sp. z o.o. · Salus International Sp. z o.o.
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 741840-2026
- First seen
- 27 Oct 2026
- Last updated
- 27 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/bb4ab3ac-6bb8-448a-a7c3-65a77e27eb25The source notice is authoritative — verify deadlines and documents there before bidding.